Your browser doesn't support javascript.
loading
The burden of multiple sclerosis variants in continental Italians and Sardinians.
Barizzone, Nadia; Zara, Ilenia; Sorosina, Melissa; Lupoli, Sara; Porcu, Eleonora; Pitzalis, Maristella; Zoledziewska, Magdalena; Esposito, Federica; Leone, Maurizio; Mulas, Antonella; Cocco, Eleonora; Ferrigno, Paola; Guerini, Franca R; Brambilla, Paola; Farina, Gabriele; Murru, Raffaele; Deidda, Francesca; Sanna, Sonia; Loi, Alessia; Barlassina, Cristina; Vecchio, Domizia; Zauli, Andrea; Clarelli, Ferdinando; Braga, Daniele; Poddie, Fausto; Cantello, Roberto; Martinelli, Vittorio; Comi, Giancarlo; Frau, Jessica; Lorefice, Lorena; Pugliatti, Maura; Rosati, Giulio; Melis, Maurizio; Marrosu, Maria G; Cusi, Daniele; Cucca, Francesco; Martinelli Boneschi, Filippo; Sanna, Serena; D'Alfonso, Sandra.
Afiliação
  • Barizzone N; Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), University of Eastern Piedmont, Novara, Italy/Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.
  • Zara I; Centro di Ricerca, Sviluppo e Studi Superiori in Sardegna, Pula Cagliari, Italy/Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche (CNR), Cittadella Universitaria di Monserrato, Cagliari, Italy.
  • Sorosina M; Laboratory of Genetics of Complex Neurological Disorders, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
  • Lupoli S; Department of Health Sciences, University of Milan, Italy.
  • Porcu E; Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche (CNR), Cittadella Universitaria di Monserrato, Cagliari, Italy/Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Italy.
  • Pitzalis M; Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche (CNR), Cittadella Universitaria di Monserrato, Cagliari, Italy.
  • Zoledziewska M; Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche (CNR), Cittadella Universitaria di Monserrato, Cagliari, Italy.
  • Esposito F; Laboratory of Genetics of Complex Neurological Disorders, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
  • Leone M; Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), University of Eastern Piedmont, Novara, Italy/SC Neurologia, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Mulas A; Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche (CNR), Cittadella Universitaria di Monserrato, Cagliari, Italy/Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Italy.
  • Cocco E; Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Italy.
  • Ferrigno P; Azienda Ospedaliera Brotzu, SC Neurologia e Stroke Unit, Cagliari, Italy.
  • Guerini FR; Don C Gnocchi Foundation IRCCS, Milan, Italy.
  • Brambilla P; Laboratory of Genetics of Complex Neurological Disorders, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
  • Farina G; Department of Clinical and Experimental Medicine, University of Sassari, Italy.
  • Murru R; Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Italy.
  • Deidda F; Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche (CNR), Cittadella Universitaria di Monserrato, Cagliari, Italy.
  • Sanna S; Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche (CNR), Cittadella Universitaria di Monserrato, Cagliari, Italy.
  • Loi A; Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche (CNR), Cittadella Universitaria di Monserrato, Cagliari, Italy/Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Italy.
  • Barlassina C; Department of Health Sciences, University of Milan, Italy.
  • Vecchio D; Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Zauli A; Laboratory of Genetics of Complex Neurological Disorders, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
  • Clarelli F; Laboratory of Genetics of Complex Neurological Disorders, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
  • Braga D; Department of Health Sciences, University of Milan, Italy.
  • Poddie F; Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Italy.
  • Cantello R; Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), University of Eastern Piedmont, Novara, Italy/Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Martinelli V; Laboratory of Genetics of Complex Neurological Disorders, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
  • Comi G; Laboratory of Genetics of Complex Neurological Disorders, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
  • Frau J; Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Italy.
  • Lorefice L; Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Italy.
  • Pugliatti M; Department of Clinical and Experimental Medicine, University of Sassari, Italy.
  • Rosati G; Department of Clinical and Experimental Medicine, University of Sassari, Italy.
  • Melis M; Azienda Ospedaliera Brotzu, SC Neurologia e Stroke Unit, Cagliari, Italy.
  • Marrosu MG; Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Italy.
  • Cusi D; Department of Health Sciences, University of Milan, Italy.
  • Cucca F; Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche (CNR), Cittadella Universitaria di Monserrato, Cagliari, Italy/Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Italy.
  • Martinelli Boneschi F; Laboratory of Genetics of Complex Neurological Disorders, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy/Department of Neurology, Division of Neuroscience, Scientific Institute San Raffaele, Milan, Italy.
  • Sanna S; Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche (CNR), Cittadella Universitaria di Monserrato, Cagliari, Italy serena.sanna@irgb.cnr.it sandra.dalfonso@med.unipmn.it.
  • D'Alfonso S; Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Mult Scler ; 21(11): 1385-95, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26438306
ABSTRACT

BACKGROUND:

Recent studies identified > 100 non-HLA (human leukocyte antigen) multiple sclerosis (MS) susceptibility variants in Northern European populations, but their role in Southern Europeans is largely unexplored.

OBJECTIVE:

We aimed to investigate the cumulative impact of those variants in two Mediterranean populations Continental Italians and Sardinians.

METHODS:

We calculated four weighted Genetic Risk Scores (wGRS), using up to 102 non-HLA MS risk variants and 5 HLA MS susceptibility markers in 1691 patients and 2194 controls from continental Italy; and 2861 patients and 3034 controls from Sardinia. We then assessed the differences between populations using Nagelkerke's R(2) and the area under the Receiver Operating Characteristic (ROC) curves.

RESULTS:

As expected, the genetic burden (mean wGRS value) was significantly higher in MS patients than in controls, in both populations. Of note, the burden was significantly higher in Sardinians. Conversely, the proportion of variability explained and the predictive power were significantly higher in continental Italians. Notably, within the Sardinian patients, we also observed a significantly higher burden of non-HLA variants in individuals who do not carry HLA risk alleles.

CONCLUSIONS:

The observed differences in MS genetic burden between the two Mediterranean populations highlight the need for more genetic studies in South Europeans, to further expand the knowledge of MS genetics.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Antígenos HLA / Esclerose Múltipla Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Antígenos HLA / Esclerose Múltipla Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article